Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXGH5Q
|
||||
| Drug Name |
1-(4-(4-amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl)phenyl)urea
|
||||
| Synonyms |
CHEMBL193752
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H17N5O3
|
||||
| Canonical SMILES |
COc1ccc(cc1)c2oc3ncnc(N)c3c2c4ccc(NC(=O)N)cc4
|
||||
| InChI |
InChI=1S/C20H17N5O3/c1-27-14-8-4-12(5-9-14)17-15(16-18(21)23-10-24-19(16)28-17)11-2-6-13(7-3-11)25-20(22)26/h2-10H,1H3,(H2,21,23,24)(H3,22,25,26)
|
||||
| InChIKey |
DVAKZOIIORDUJI-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.